ONXX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.
Onyx Pharmaceuticals, Inc.'s cash flow for capital expenditures for the three months ended in Jun. 2013 was $-4.6 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2013 was $-6.0 Mil.
Onyx Pharmaceuticals, Inc. Cash Flow for Capital Expenditures for the trailing twelve months (TTM) ended in Jun. 2013 was 6.45 (Sep. 2012 ) + -1.761 (Dec. 2012 ) + -6.09 (Mar. 2013 ) + -4.606 (Jun. 2013 ) = $-6.0 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Onyx Pharmaceuticals, Inc. Annual Data
Onyx Pharmaceuticals, Inc. Quarterly Data